Selected Reaction Monitoring Market Size, Share, Competitive Landscape and Trend Analysis Report, by Assay Type, by Application and, by End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

Selected reaction monitoring method is the highly selective and sensitive method for the quantification of protein and peptide in a complex biological sample during mass spectrometry.

It uses mass spectroscopy, which specifically targets and detects the required proteins and specifically look for peptides and protein fragments of interest. Increase in R&D in the field of biology is expected to drive the market during the analysis period. However, selected reaction monitoring process is time consuming and hence anticipated to inhibit the growth of the market.

The market is segmented based on assay type, application, end users, and geography. By assay type, it is categorized into custom assay, human discovery assay, human cancer assay, and human cardiovascular assay.

By application, it is bifurcated into biomarker assessment and MRM-MS quality control. By end users, it is divided into hospitals, diagnostic centers, and research institutes. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.

Key Benefits

• Comprehensive analysis of factors that drive and restrict the growth of the global selected reaction monitoring market is provided.
• The projections in the market are made by studying the current market trends and future market potential for the in terms of value.
• Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective market.
• Key market players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the market.
• Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies.

  Selected Reaction Monitoring Market Report Highlights

Aspects	Details
By Assay Type	Custom Assay Human Discovery Assay Human Cancer Assay Human Cardiovascular Assay
By Application	Biomarker Assessment MRM-MS Quality Control Platform Performance Workflow Performance
By End Users	Hospitals Diagnostic Centers Research Institutes
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Illumina, Inc., MRM Proteomics, Luminex Corporation, Alphalyse, Sigma Aldrich, Qiagen N.V., Becton, Dickinson and Company, Proteomics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc.
List of other players (These companies are not profiled in the report and same can be done on demand)	Abcam PLC, Seegene Inc., Meso Scale Diagnostics, LLC, Randox Laboratories Ltd

^*Terms and Conditions Apply